115 related articles for article (PubMed ID: 3121598)
1. Activation of human endothelial cell-type plasminogen activator inhibitor (PAI-1) by negatively charged phospholipids.
Lambers JW; Cammenga M; König BW; Mertens K; Pannekoek H; van Mourik JA
J Biol Chem; 1987 Dec; 262(36):17492-6. PubMed ID: 3121598
[TBL] [Abstract][Full Text] [Related]
2. Kinetic analysis of the interactions between plasminogen activator inhibitor 1 and both urokinase and tissue plasminogen activator.
Hekman CM; Loskutoff DJ
Arch Biochem Biophys; 1988 Apr; 262(1):199-210. PubMed ID: 3128176
[TBL] [Abstract][Full Text] [Related]
3. Plasminogen activator inhibitor-1 binds to fibrin and inhibits tissue-type plasminogen activator-mediated fibrin dissolution.
Reilly CF; Hutzelmann JE
J Biol Chem; 1992 Aug; 267(24):17128-35. PubMed ID: 1512250
[TBL] [Abstract][Full Text] [Related]
4. Denaturant-induced stimulation of the beta-migrating plasminogen activator inhibitor in endothelial cells and serum.
Erickson LA; Hekman CM; Loskutoff DJ
Blood; 1986 Dec; 68(6):1298-305. PubMed ID: 2430646
[TBL] [Abstract][Full Text] [Related]
5. Endothelial cells produce a latent inhibitor of plasminogen activators that can be activated by denaturants.
Hekman CM; Loskutoff DJ
J Biol Chem; 1985 Sep; 260(21):11581-7. PubMed ID: 3930479
[TBL] [Abstract][Full Text] [Related]
6. Purification of active human plasminogen activator inhibitor 1 from Escherichia coli. Comparison with natural and recombinant forms purified from eucaryotic cells.
Lawrence D; Strandberg L; Grundström T; Ny T
Eur J Biochem; 1989 Dec; 186(3):523-33. PubMed ID: 2514093
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of protein C-dependent clot lysis: role of plasminogen activator inhibitor.
Sakata Y; Loskutoff DJ; Gladson CL; Hekman CM; Griffin JH
Blood; 1986 Dec; 68(6):1218-23. PubMed ID: 3096399
[TBL] [Abstract][Full Text] [Related]
8. Interaction of tissue-type plasminogen activator and plasminogen activator inhibitor 1 on the surface of endothelial cells.
Sakata Y; Okada M; Noro A; Matsuda M
J Biol Chem; 1988 Feb; 263(4):1960-9. PubMed ID: 3123483
[TBL] [Abstract][Full Text] [Related]
9. Activated protein C increases fibrin clot lysis by neutralization of plasminogen activator inhibitor--no evidence for a cofactor role of protein S.
de Fouw NJ; de Jong YF; Haverkate F; Bertina RM
Thromb Haemost; 1988 Oct; 60(2):328-33. PubMed ID: 2975409
[TBL] [Abstract][Full Text] [Related]
10. Purification and characterization of a plasminogen activator inhibitor 1 binding protein from human plasma. Identification as a multimeric form of S protein (vitronectin).
Declerck PJ; De Mol M; Alessi MC; Baudner S; Pâques EP; Preissner KT; Müller-Berghaus G; Collen D
J Biol Chem; 1988 Oct; 263(30):15454-61. PubMed ID: 2459123
[TBL] [Abstract][Full Text] [Related]
11. Bovine endothelial cell plasminogen activator inhibitor. Purification and heat activation.
Katagiri K; Okada K; Hattori H; Yano M
Eur J Biochem; 1988 Sep; 176(1):81-7. PubMed ID: 3262060
[TBL] [Abstract][Full Text] [Related]
12. Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes to fibrin mediated by both the finger and the kringle-2 domain of t-PA.
Wagner OF; de Vries C; Hohmann C; Veerman H; Pannekoek H
J Clin Invest; 1989 Aug; 84(2):647-55. PubMed ID: 2503541
[TBL] [Abstract][Full Text] [Related]
13. Identification of a conformationally distinct form of plasminogen activator inhibitor-1, acting as a noninhibitory substrate for tissue-type plasminogen activator.
Declerck PJ; De Mol M; Vaughan DE; Collen D
J Biol Chem; 1992 Jun; 267(17):11693-6. PubMed ID: 1601844
[TBL] [Abstract][Full Text] [Related]
14. Vitronectin governs the interaction between plasminogen activator inhibitor 1 and tissue-type plasminogen activator.
Keijer J; Ehrlich HJ; Linders M; Preissner KT; Pannekoek H
J Biol Chem; 1991 Jun; 266(16):10700-7. PubMed ID: 1709939
[TBL] [Abstract][Full Text] [Related]
15. The formation of complexes between human plasminogen activator inhibitor-1 (PAI-1) and sodium dodecyl sulfate: possible implication in the functional properties of PAI-1.
Gaussem P; Anglés-Cano E
Biochim Biophys Acta; 1991 Sep; 1079(3):321-9. PubMed ID: 1911857
[TBL] [Abstract][Full Text] [Related]
16. Presence of active and latent type 1 plasminogen activator inhibitor associated with porcine platelets.
Lang IM; Marsh JJ; Moser KM; Schleef RR
Blood; 1992 Nov; 80(9):2269-74. PubMed ID: 1421397
[TBL] [Abstract][Full Text] [Related]
17. Cytokine activation of vascular endothelium. Effects on tissue-type plasminogen activator and type 1 plasminogen activator inhibitor.
Schleef RR; Bevilacqua MP; Sawdey M; Gimbrone MA; Loskutoff DJ
J Biol Chem; 1988 Apr; 263(12):5797-803. PubMed ID: 3128548
[TBL] [Abstract][Full Text] [Related]
18. Highly stable plasminogen activator inhibitor type one (VLHL PAI-1) protects fibrin clots from tissue plasminogen activator-mediated fibrinolysis.
Jankun J; Aleem AM; Selman SH; Skrzypczak-Jankun E; Lysiak-Szydlowska W; Grafos N; Fryer HJ; Greenfield RS
Int J Mol Med; 2007 Nov; 20(5):683-7. PubMed ID: 17912461
[TBL] [Abstract][Full Text] [Related]
19. Fibrinolysis in normal subjects--comparison between plasminogen activator inhibitor and other components of the fibrinolytic system.
Nicoloso G; Hauert J; Kruithof EK; Van Melle G; Bachmann F
Thromb Haemost; 1988 Apr; 59(2):299-303. PubMed ID: 3133812
[TBL] [Abstract][Full Text] [Related]
20. Thrombin neutralizes plasminogen activator inhibitor 1 (PAI-1) that is complexed with vitronectin in the endothelial cell matrix.
Ehrlich HJ; Gebbink RK; Preissner KT; Keijer J; Esmon NL; Mertens K; Pannekoek H
J Cell Biol; 1991 Dec; 115(6):1773-81. PubMed ID: 1721912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
